These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 9836013)

  • 21. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT. Binding kinetics in the human brain.
    Brücke T; Kornhuber J; Angelberger P; Asenbaum S; Frassine H; Podreka I
    J Neural Transm Gen Sect; 1993; 94(2):137-46. PubMed ID: 8110440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry.
    Riikonen RS; Nokelainen P; Valkonen K; Kolehmainen AI; Kumpulainen KI; Könönen M; Vanninen RL; Kuikka JT
    Biol Psychiatry; 2005 Jun; 57(12):1565-72. PubMed ID: 15953494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
    Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.
    Owens MJ; Nemeroff CB
    Clin Chem; 1994 Feb; 40(2):288-95. PubMed ID: 7508830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin transporter binding in Tourette Syndrome.
    Müller-Vahl KR; Meyer GJ; Knapp WH; Emrich HM; Gielow P; Brücke T; Berding G
    Neurosci Lett; 2005 Sep; 385(2):120-5. PubMed ID: 15936877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new model for separation between brain dopamine and serotonin transporters in 123I-beta-CIT SPECT measurements: normal values and sex and age dependence.
    Ryding E; Lindström M; Brådvik B; Grabowski M; Bosson P; Träskman-Bendz L; Rosén I
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1114-8. PubMed ID: 15014902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reproducibility of iodine-123-beta-CIT SPECT brain measurement of dopamine transporters.
    Seibyl JP; Laruelle M; van Dyck CH; Wallace E; Baldwin RM; Zoghbi S; Zea-Ponce Y; Neumeyer JL; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Feb; 37(2):222-8. PubMed ID: 8667048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SPECT-evaluation of the monoamine uptake site ligand [123I](1R)-2-beta-carbomethoxy-3-beta-(4-iodophenyl)-tropane ([123I]beta-CIT) in untreated patients with suspicion of Parkinson disease.
    Eising EG; Müller TT; Zander C; Kuhn W; Farahati J; Reiners C; Coenen HH
    J Investig Med; 1997 Oct; 45(8):448-52. PubMed ID: 9394097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents.
    Dahlström M; Ahonen A; Ebeling H; Torniainen P; Heikkilä J; Moilanen I
    Mol Psychiatry; 2000 Sep; 5(5):514-22. PubMed ID: 11032385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seasonal variation of availability of serotonin transporter binding sites in healthy female subjects as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.
    Neumeister A; Pirker W; Willeit M; Praschak-Rieder N; Asenbaum S; Brücke T; Kasper S
    Biol Psychiatry; 2000 Jan; 47(2):158-60. PubMed ID: 10664833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
    J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    Wall SC; Innis RB; Rudnick G
    Mol Pharmacol; 1993 Feb; 43(2):264-70. PubMed ID: 8429827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin transporter binding with [123I]beta-CIT SPECT in major depressive disorder versus controls: effect of season and gender.
    Ruhé HG; Booij J; Reitsma JB; Schene AH
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):841-9. PubMed ID: 19183998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Imaging of serotonin and dopamine transporters in the living human brain.
    Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Hartikainen P; Viinamäki H; Länsimies E; Lehtonen J; Hakola P
    Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
    Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
    World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [123I]beta-CIT SPECT imaging of dopamine transporter availability after mazindol administration in human cocaine addicts.
    Malison RT; McCance E; Carpenter LL; Baldwin RM; Seibyl JP; Price LH; Kosten TR; Innis RB
    Psychopharmacology (Berl); 1998 Jun; 137(4):321-5. PubMed ID: 9676890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies on platelet serotonin transporter binding in depression.
    Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
    Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.